FDA official logo
GSRS logoPFDA official logo

(3S,4S)-(4R)-4,5-DIHYDROXY-1-(4-(5-(4-(PENTYLOXY)PHENYL)-3-ISOXAZOLYL)BENZOYL)-L-PROLYL-L-THREONYL-(4R)-4-HYDROXY-L-PROLYL-(4S)-4-HYDROXY-4-(4-HYDROXY-3-(SULFOOXY)PHENYL)-L-THREONYL-(3R)-3-HYDROXY-L-GLUTAMINYL-3-HYDROXY-4-METHYL-L-PROLINAMIDE SODIUM

UNII:9C62ZSN8N2
Type:INGREDIENT SUBSTANCE
Formula:C56H70N9O23S.Na
Preferred Substance Name:(3S,4S)-(4R)-4,5-DIHYDROXY-1-(4-(5-(4-(PENTYLOXY)PHENYL)-3-ISOXAZOLYL)BENZOYL)-L-PROLYL-L-THREONYL-(4R)-4-HYDROXY-L-PROLYL-(4S)-4-HYDROXY-4-(4-HYDROXY-3-(SULFOOXY)PHENYL)-L-THREONYL-(3R)-3-HYDROXY-L-GLUTAMINYL-3-HYDROXY-4-METHYL-L-PROLINAMIDE SODIUM
InChIKey:
GSRS Full Record:

  • 539823-82-0
  • (3S,4S)-(4R)-4,5-Dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-L-prolinamide sodium
  • L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt (1:1), (3S,4S)-
  • L-Prolinamide, (4R)-4,5-dihydroxy-1-[4-[5-[4-(pentyloxy)phenyl]-3-isoxazolyl]benzoyl]-L-prolyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-, sodium salt, (3S,4S)-
  • Micafungin open ring impurity
  • Micafungin open-ring analog sodium salt
  • Sodium [5-[(1S,2S,3S)-4-[[(2S,3R)-5-amino-1-[(2S,3S,4S)-2-carbamoyl-3-hydroxy-4-methylpyrrolidin-1-yl]-3-hydroxy-1,5-dioxopentan-2-yl]amino]-3-[[(2S,4R)-1-[(2S,3R)-2-[[(2S,4R)-4,5-dihydroxy-1-[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-1,2-dihydroxy-4-oxobutyl]-2-hydroxyphenyl] sulfate



UNII - 9C62ZSN8N2 | UNII Search Service